Skip to main content

Table 1 GFAP-positive meningiomas; review of cases in the literature

From: A rare case of intramedullary ‘whorling-sclerosing’ variant meningioma

References

Age/gender

Location

Histological diagnosis

Immunohistochemistry

Positive

Negative

Budka (1986)

48 years/F

Extra-axial left parietal

Papillary meningioma

GFAP, vimentin, cytokeratin

 

Wanschitz et al. (1995)

24 years/F

Suprasellar

Chordoid or papillary meningioma

GFAP, NSE, S100, vimentin, cytokeratin, and EMA

SYN, NFP, CHROM A, CEA, FN, desmin, MU 128-UC

Su et al. (1997)

63 years/M

Extra-axial in the right superior and medial frontal gyri

Atypical meningioma: meningiothelial type

EMA, vimentin, GFAP

S 100 protein

Haberler et al. (2002)

48 years/F

Bifronto-basal invading skull base, sinuses and orbit

Whorling-sclerosing variant of meningioma

S100 protein, vimentin, EMA, CD34, GFAP

Cytokeratin, progesterone, desmin

Haberler et al. (2002)

77 years/M

Dural based right occipital

Whorling-sclerosing variant of meningioma

EMA, cytokeratin, desmin, S100, vimentin, GFAP

CD34, pancytokeratin, progesterone

Pope et al. (2003)

34 years/M

Dura of mesencephalon and pons

Whorling-sclerosing variant of meningioma

EMA, vimentin, GFAP

Cytokeratin, CEA

  1. GFAP glial fibrillary acidic protein, NSE neuron specific enolase, EMA epithelial membrane antigen, SYN synaptophysin, NFP neurofilament protein, CHROM A chromogranin A, FN fibronectin, CEA carciniembryonic antigen, MU 128-UC smooth muscle actin.